Parsing the subsets: When small studies create confusion.

Suppr

超能文献

作者信息

Blankenship James C

出版信息

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):23-4. doi: 10.1002/ccd.21648.

DOI:10.1002/ccd.21648

PMID:18561152

Abstract

摘要

相似文献

Parsing the subsets: When small studies create confusion.

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):23-4. doi: 10.1002/ccd.21648.

DES in saphenous bypass grafts: A treatment in vain?

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):21-2. doi: 10.1002/ccd.21649.

Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis.

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):7-12. doi: 10.1002/ccd.21566.

Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?

Catheter Cardiovasc Interv. 2008 Nov 15;72(6):815-8. doi: 10.1002/ccd.21657.

Revitalizing embolic protection in saphenous vein grafts.

Catheter Cardiovasc Interv. 2010 Aug 1;76(2):270-1. doi: 10.1002/ccd.22708.

Approach to the patient with prior bypass surgery.

J Interv Cardiol. 2004 Oct;17(5):339-46. doi: 10.1111/j.1540-8183.2004.04033.x.

Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.

J Am Coll Cardiol. 2008 Mar 4;51(9):970-1; author reply 971-2. doi: 10.1016/j.jacc.2007.08.068.

Double jeopardy, double trouble.

Catheter Cardiovasc Interv. 2010 Aug 1;76(2):279-80. doi: 10.1002/ccd.22709.

Drug-eluting stents in ST elevation myocardial infarction: In light of the PROSIT trial.

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):33-5. doi: 10.1002/ccd.21652.

Beyond embolic protection for saphenous vein graft disease.

Catheter Cardiovasc Interv. 2008 Nov 1;72(5):641-2. doi: 10.1002/ccd.21827.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Parsing the subsets: When small studies create confusion.

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):23-4. doi: 10.1002/ccd.21648.

DES in saphenous bypass grafts: A treatment in vain?

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):21-2. doi: 10.1002/ccd.21649.

Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis.

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):7-12. doi: 10.1002/ccd.21566.

Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?

Catheter Cardiovasc Interv. 2008 Nov 15;72(6):815-8. doi: 10.1002/ccd.21657.

Revitalizing embolic protection in saphenous vein grafts.

Catheter Cardiovasc Interv. 2010 Aug 1;76(2):270-1. doi: 10.1002/ccd.22708.

Approach to the patient with prior bypass surgery.

J Interv Cardiol. 2004 Oct;17(5):339-46. doi: 10.1111/j.1540-8183.2004.04033.x.

Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.

J Am Coll Cardiol. 2008 Mar 4;51(9):970-1; author reply 971-2. doi: 10.1016/j.jacc.2007.08.068.

Double jeopardy, double trouble.

Catheter Cardiovasc Interv. 2010 Aug 1;76(2):279-80. doi: 10.1002/ccd.22709.

Drug-eluting stents in ST elevation myocardial infarction: In light of the PROSIT trial.

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):33-5. doi: 10.1002/ccd.21652.

Beyond embolic protection for saphenous vein graft disease.

Catheter Cardiovasc Interv. 2008 Nov 1;72(5):641-2. doi: 10.1002/ccd.21827.